Universal Ibogaine Inc. Share Price Toronto S.E.
Equities
IBO
CA69379R1082
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 CAD | -33.33% | -33.33% | +100.00% |
04-22 | Universal Ibogaine Inc. announced that it expects to receive CAD 0.35 million in funding | CI |
04-12 | Universal Ibogaine Inc. announced that it expects to receive CAD 0.6 million in funding | CI |
Sales 2022 | 1.07 1.46 85.44 | Sales 2023 | 1.03 1.41 82.18 | Capitalization | 2.87M 3.92M 229M |
---|---|---|---|---|---|
Net income 2022 | -10M -13.65M -798M | Net income 2023 | -2M -2.73M -160M | EV / Sales 2022 | 8,069,982 x |
Net Debt 2022 | 1.01M 1.38M 80.72M | Net Debt 2023 | 2.46M 3.36M 197M | EV / Sales 2023 | 5,181,017 x |
P/E ratio 2022 |
-0.67
x | P/E ratio 2023 |
-1.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
1 day | -33.33% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Karos
CEO | Chief Executive Officer | - | 09/01/22 |
Greg J. Leavens
DFI | Director of Finance/CFO | 59 | - |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Nicholas Karos
CEO | Chief Executive Officer | - | 09/01/22 |
James Duncan
BRD | Director/Board Member | - | 30/09/23 |
1st Jan change | Capi. | |
---|---|---|
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+11.62% | 29.59B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.23% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- IBO Stock
- IBO Stock